Latest AlzeCure Pharma News & Updates

See the latest news and media coverage for AlzeCure Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AlzeCure Pharma

Swedish pharmaceutical company developing neurological disease treatments

alzecurepharma.se
Headquarters
Stockholm, Sweden
Founded year
2016
Company type
Public company
Number of employees
15–50
Industry
Pharmaceuticals

Last updated

Latest news about AlzeCure Pharma

In short: AlzeCure Pharma turned to profit after securing licensing deals with Eli Lilly and QuantumCell worth over $3 billion in potential value.

Company announcements

AlzeCure Pharma

AlzeCure Pharma resolves on directed share issue to QuantumCell

The board decided to issue 9,926,099 new shares to QuantumCell at SEK 4.91 per share, as part of a licensing agreement payment.

Unlock all announcements with a

Media coverage

Longevity.Technology

AlzeCure banks $10m as Lilly deal closes

It’s not a huge number by pharma standards, but it’s the opening move in a deal that could eventually be worth more than a billion...

Yahoo Finance

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

Eli Lilly (LLY) paid AlzeCure Pharma a $10 million upfront payment and completed the initial transaction under their collaboration and licensing agreement for the Alzheimer's...

Unlock all articles with a

Never miss news about AlzeCure Pharma

Track AlzeCure Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AlzeCure Pharma competitors & trending companies

Browse news for competitors to AlzeCure Pharma and other trending companies.